Biotech Clusters in British Columbia

Document Sample
Biotech Clusters in British Columbia Powered By Docstoc
					Biotech Clusters in British Columbia
 Our Vision

  To be the catalyst for a life sciences
  cluster of genomics-related research
  institutions and companies working
together for the socio-economic benefit
     of British Columbia and Canada.
  Our History
• Motivated by the late Dr. Michael Smith, Genome
  British Columbia was formed in July 2000 by a Board
  comprised of leaders in BC’s life science research,
  technology and investment sectors

• Competition I projects and platforms were announced
  in April 2001, with an investment in BC of $69M;
  Competition II projects were announced in April 2002,
  with a direct investment in BC of $32M and indirect
  investment in BC of another $13M for a total of $114M

• The Applied Health Competition was announced in April
  2004 with approved projects in BC of $44M
Biotechnology in British
Columbia – Reference: BC Biotech (2004)
• BC’s biotechnology industry comprises over 90
  private sector firms

• British Columbia is home to the seventh largest
  biotech cluster in North America based on the
  number of biotech companies

• The majority of biotechnology companies in BC
  have been spun off from the province’s
  universities, affiliated teaching hospitals and
  public sector research institutions
Biotechnology in British
Columbia – Reference: BC Biotech (2004)
• BC’s biotechnology industry is dominated by firms
  in the health care sector (60%), companies
  developing biopharmaceutical and biomedical
  applications

• BC is the fastest growing biotech sector in Canada
  with a 108% growth rate in the number of core
  biotech companies from 1997 to 2001
Biotechnology in British
Columbia – Reference: BC Biotech (2004)
• Between 1991 and 2001, 60 biotechnology
  companies were created in Vancouver, making it
  the third fastest growing in North America, with
  only San Francisco (71) and Boston (65) having
  founded more companies in that decade

• In 2003, British Columbia accounted for 47% of all
  public and 34% of all private biotech financings in
  Canada. Total investment in public companies in
  BC in 2003 was $789,852,500; and total
  investment in private companies in BC in 2003 was
  $83,400,000
Biotechnology in British
Columbia – Reference: BC Biotech (2004)
• Total venture capital funding for biotech firms in
  Vancouver from 1998 to 2001 was US$204.1
  million compared to the average of US$191.3
  million among 52 US centres examined

• 2002 revenue among BC’s top biotech companies
  was $165.88 million

• Total estimated employment by Vancouver
  biotechnology firms is 2,593. The pharmaceutical
  industry employs an additional 1,121
Reference: White Paper: PwC 2003
Reference: White Paper: PwC 2003
Reference: White Paper: PwC 2003
Reference: White Paper: PwC 2003
Reference: White Paper: PwC 2003
Reference: White Paper: PwC 2003
Reference: White Paper: PwC 2003
Cluster Development – Factors
• CRISIS
   – eg. Ottawa

• PAN POLITICAL
   – eg. Oregon

• CHAMPIONS
   – eg. Terry Mathews
Cluster Development – Factors
• ANGELS
   – eg. Denny Doyle

• MENTORS AND BOARDS
   – eg. Haig Farris

• UNIVERSITIES
   – eg. UBC Spin-offs
Cluster Development – Factors
• COMPANIES
   – eg. MPR, QLT

• 4th PILLAR ORGANIZATIONS
    – eg. OCRI; AceTech; Genome BC
Cluster Development – Factors
• NATIONAL
   – eg. Economical and political sovereignty
      • NAFTA / city states model
      • National model
Summary
• Technology clusters have not reached their potential
  in BC



• However, the biotech cluster in BC is well-positioned
  for growth




                 Reference: The State of Biotechnology in Canada:
                 Current research from the ISRN: May 2004